Svelte Medical Systems is a healthcare company engaged in the design and development of highly deliverable balloon expandable stents.
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products.Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 7, 2009 | Debt Financing | $6M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Norwich Ventures | — | Debt Financing |